Of those 20 HLA-DRB1*15 positive patients, 7 (35%) had refractory sJIA, as defined by Erkens (1), compared to 14 (17%) of the HLA-DRB1*15 negative patients. Here, HLA-DRB1 is linked to systemic-onset juvenile idiopathic arthritis.